top of page
Back to Projects
Managing Obesity .jpg

Abnormal Uterine Bleeding: data project

Women’s & Reproductive Health (Obstetrics & Gynecology), Primary Care / Family Medicine
2025-04-01 – undefined

Raising awareness about considering endometrial biopsies in younger women - Introduction here

Why this project matters

Abnormal uterine bleeding is one of the most common reasons women seek gynecologic care, and it is often the first sign of endometrial cancer, the most common gynecologic cancer in high-income countries. Endometrial cancer has long been seen as a disease of older women, but more cases are now being diagnosed in younger women. Abnormal uterine bleeding in younger women is common and usually benign, so it can be treated for years without deeper investigation, such as an endometrial biopsy, a quick procedure that can be done in a family physician’s office. Canadian guidelines recommend a biopsy for women whose bleeding persists despite treatment, or who have risk factors for endometrial cancer, regardless of age. Recognising cancer earlier means opportunities for treatment and better outcomes for patients. It also means fewer repeat clinic and emergency department visits, which matters for a health system under pressure.

 

What we did

The project took two complementary approaches. First, we analysed Alberta health data covering more than 5,400 women diagnosed with endometrial cancer between 2013 and 2023, tracing the care they received in the years before diagnosis and comparing patterns across age groups. Second, we delivered webinars and hands-on workshops that built family physicians’ skills and confidence in endometrial biopsy and related office procedures, such as intrauterine device (IUD) insertion. The data findings are now being built into these ongoing sessions and into teaching for residents, and they give us a baseline for measuring change over time.

 

Who was involved

This project was led by PLP Medical Director Dr. Darren Lau and PLP physician lead Dr. Sanja Kostov. PLP team members included: Dr. Denise Campbell-Scherer, Nicole Ofosu and Laurel Collier.

 

What we found

Endometrial cancer in women under 45 is not rare. Of the 5,409 women diagnosed in Alberta between 2013 and 2023, 402 (7.4%) were under 45. Most women had abnormal bleeding recorded in their health records before diagnosis, yet only about a third had ever had an endometrial biopsy, and most biopsies were done around the time of diagnosis, not to investigate earlier bleeding.

Women under 45 stood out. They were more likely to have been treated repeatedly for heavy bleeding and iron deficiency, more likely to have related conditions such as polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS), and about one in five visited an emergency department for bleeding in the year before their diagnosis. Their care often matched the situations where guidelines recommend a biopsy. These insights are now shaping our family physician workshops and teaching for residents, with a clear message: in women with persistent bleeding, while on treatment such as tranexamic acid or iron, alongside PMOS, obesity or iron deficiency, age alone should not rule out an endometrial biopsy.

Related to this project
Project Events
Project Tools
bottom of page